The return of the Aids plague

Brazil's efforts to secure affordable medicine for its 600,000 HIV patients is making Big Pharma shiver - but treatment for suffering millions in the global south will be a long campaign.

A global regime where private corporations can enforce intellectual property rights to the detriment of public health is bad news for the millions most vulnerable to HIV/Aids, reports Tom Burgis.